MedPath

Benzphetamine Hydrochloride

Benzphetamine Hydrochloride Tablets, CIIIRx Only

Approved
Approval ID

f6d9b369-4b64-4d3f-844d-5d60dd257c55

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 27, 2023

Manufacturers
FDA

Epic Pharma, LLC

DUNS: 827915443

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Benzphetamine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42806-081
Application NumberANDA090346
Product Classification
M
Marketing Category
C73584
G
Generic Name
Benzphetamine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateDecember 27, 2023
FDA Product Classification

INGREDIENTS (12)

BENZPHETAMINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 1
Code: 43DWT87QT7
Classification: ACTIB
CROSPOVIDONE, UNSPECIFIEDInactive
Code: 2S7830E561
Classification: IACT
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE 2910 (15 MPA.S)Inactive
Code: 36SFW2JZ0W
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
POLYETHYLENE GLYCOL 800Inactive
Code: UH6KR4953D
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.